2783 related articles for article (PubMed ID: 26928656)
21. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
Raimondo S; Giavaresi G; Lorico A; Alessandro R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
[TBL] [Abstract][Full Text] [Related]
23. Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications.
Jeyaram A; Jay SM
AAPS J; 2017 Nov; 20(1):1. PubMed ID: 29181730
[TBL] [Abstract][Full Text] [Related]
24. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
Zarà M; Guidetti GF; Camera M; Canobbio I; Amadio P; Torti M; Tremoli E; Barbieri SS
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212641
[TBL] [Abstract][Full Text] [Related]
25. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
[TBL] [Abstract][Full Text] [Related]
26. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
27. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Vesicles in Cardiovascular Theranostics.
Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
[TBL] [Abstract][Full Text] [Related]
29. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
Ingato D; Lee JU; Sim SJ; Kwon YJ
J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
Burnouf T; Agrahari V; Agrahari V
Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
[TBL] [Abstract][Full Text] [Related]
32. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
33. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
Kotmakçı M; Bozok Çetintaş V
J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
[TBL] [Abstract][Full Text] [Related]
35. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
[TBL] [Abstract][Full Text] [Related]
36. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems.
Lu M; Xing H; Xun Z; Yang T; Zhao X; Cai C; Wang D; Ding P
Eur J Pharm Sci; 2018 Aug; 121():34-46. PubMed ID: 29733979
[TBL] [Abstract][Full Text] [Related]
37. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
[TBL] [Abstract][Full Text] [Related]
38. Extracellular Vesicles as Drug Transporters.
Nowak M; Górczyńska J; Kołodzińska K; Rubin J; Choromańska A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373411
[TBL] [Abstract][Full Text] [Related]
39. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
40. Extracellular vesicles as delivery systems at nano-/micro-scale.
Fu P; Zhang J; Li H; Mak M; Xu W; Tao Z
Adv Drug Deliv Rev; 2021 Dec; 179():113910. PubMed ID: 34358539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
